These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4896968)

  • 1. Treatment of generalized lymphogranulomatosis and reticuloendothelioma with Vinblastin.
    Gersanovich MH; Danova LA; Labkowsky BM; Levitskaya NA; Medvediev ML; Neustadt VN; Chekhorina EA
    Ther Hung; 1969; 17(2):61-5. PubMed ID: 4896968
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of vinblastine in the treatment of malignant lymphomas].
    Eridani S; Esposito R; Ponti GB; Giangrande A
    Cancro; 1968; 21():Suppl 6:102+. PubMed ID: 4906143
    [No Abstract]   [Full Text] [Related]  

  • 3. Vinblastine treatment of malignant lymphomas.
    Klener P; Donner L; Neuwirtová R; Ort J
    Neoplasma; 1971; 18(5):505-11. PubMed ID: 4940935
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of lymphoma with mechlorethamine and vinblastine.
    Solomon J; Jacobs EM; Bateman JR; Lukes RJ; Weiner JM; Donohue DM
    Arch Intern Med; 1973 Mar; 131(3):407-17. PubMed ID: 4569376
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience with vinblastine in the treatment of lymphoblastomas].
    Capretti G
    Cancro; 1968; 21():Suppl 6:93-7. PubMed ID: 4906146
    [No Abstract]   [Full Text] [Related]  

  • 6. Initial clinical experience with vinglycinate sulfate, a molecular modification of vinblastine.
    Armstrong JG; Dyke RW; Fouts PJ; Hawthorne JJ; Jansen CJ; Peabody AM
    Cancer Res; 1967 Feb; 27(2):221-7. PubMed ID: 5335120
    [No Abstract]   [Full Text] [Related]  

  • 7. Experiences with the Vinblastin treatment of lymphogranulomatosis.
    Gráf F
    Ther Hung; 1969; 17(2):71-5. PubMed ID: 5807611
    [No Abstract]   [Full Text] [Related]  

  • 8. Laboratory examinations in patients suffering from generalized lymphogranulomatosis and tumorous reticulosis treated with Vinblastin with special regard to evaluation of the efficiency and toxicity of the drug.
    Neustadt VN
    Ther Hung; 1969; 17(2):67-70. PubMed ID: 5807610
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experience in the treatment of malignant lymphomas with Vinca rosea alkaloids].
    Prato V; Mazza U; Uslenghi E; Battistini V; Bianco G
    Cancro; 1968; 21():Suppl 6:79-85. PubMed ID: 4906145
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].
    Cajozzo A; Citarrella P; Carreca I; D'Eredità F
    Haematologica; 1970; 55(7):465-70. PubMed ID: 4996520
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent advances in chemotherapy of lymphoma.
    Lenhard RE; Owens AH
    Johns Hopkins Med J; 1967 Aug; 121(2):136-40. PubMed ID: 5340335
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vincaleukoblastine in the therapy of malignant neoplasms].
    Rotolo V
    Friuli Med; 1968; 23(1):31-52. PubMed ID: 4910040
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of vinblastine for maintenance therapy in malignant lymphomas.
    Klener P; Donner L; Ort J
    Neoplasma; 1974; 21(3):323-9. PubMed ID: 4608740
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of lymph-node tumours with Vinblastin.
    Eckhardt S
    Ther Hung; 1969; 17(2):57-9. PubMed ID: 5820144
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of vincaleukoblastine in the treatment of Hodgkin's disease and other hematosarcomas and leukemias].
    Mathé G; Schweisguth O; Schneider M; Amiel JL; Cattan A; Schwarzenberg L; Brulé G; Smadja R
    Sem Ther; 1964 May; 40(5):320-4. PubMed ID: 4861409
    [No Abstract]   [Full Text] [Related]  

  • 16. Vinblastine sulfate vs cyclophosphamide in the therapy for lymphoma.
    Stutzman L; Ezdinli EZ; Stutzman MA
    JAMA; 1966 Jan; 195(3):173-8. PubMed ID: 5322863
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of lymphogranulomatosis with vinblastine].
    Persits IuIa
    Vopr Onkol; 1970; 16(3):99-112. PubMed ID: 5419658
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vinblastine treatment of a female patient with the generalized form of lymphogranulomatosis with central nervous system lesions].
    Ibrazimova FSh; Magagina GE; Pevzner TN
    Probl Gematol Pereliv Krovi; 1969 Feb; 14(2):49-51. PubMed ID: 5351086
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with Natulan in the treatment of lymphogranulomatosis and reticulosarcomatosis].
    Wagner K; Haas H; Meyerhold A
    Wien Klin Wochenschr; 1965 Sep; 77(36):589-602. PubMed ID: 5323247
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of vinblastine in the late stages of lymphogranulomatosis].
    Anikin BS; Nesterovich NA
    Klin Med (Mosk); 1974 Oct; 52(10):105-9. PubMed ID: 4437057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.